ZyCal Bioceuticals Healthcare Company, Inc., et al.

Last Updated:
Case Status:
Federal Trade Commission, Plaintiff v. ZyCal Bioceuticals Healthcare Company, Inc., a corporation, James J. Scaffidi; Excellent Marketing Results, Inc., a corporation; and Michael McGahee, Defendants.
FTC Matter/File Number:

182 3133

Civil Action Number:


Federal Court:
District of Massachusetts

Case Summary

In February 2020, the FTC filed a complaint against ZyCal Bioceuticals, a company that marketed a line of joint pain relief products under the brand name Ostinol. The same complaint includes allegations against another company Excellent Marketing Results, Inc. (EMR), which marketed a pill called StimTein through infomercials and online. EMR and its president have agreed to settle the FTC’s complaint, and are prohibited from making health-related product claims unless such claims are supported by competent and reliable scientific evidence.